In the BioHarmony Drug Report Database

"Preview" Icon

Nicotine

Habitrol, Nicoderm Cq, Nicotrol, Prostep (nicotine) is a small molecule pharmaceutical. Nicotine was first approved as Habitrol on 1996-03-22. It is used to treat tobacco use disorder and ulcerative colitis in the USA. It is known to target transient receptor potential cation channel subfamily A member 1, P2Y purinoceptor 11, hydroxycarboxylic acid receptor 1, neuronal acetylcholine receptor subunit alpha-4, hydroxycarboxylic acid receptor 2, transient receptor potential cation channel subfamily M member 2, potassium voltage-gated channel subfamily D member 3, neuronal acetylcholine receptor subunit alpha-9, hydroxycarboxylic acid receptor 3, neuronal acetylcholine receptor subunit alpha-10, and neuronal acetylcholine receptor subunit alpha-3. Rugby nicotine polacrilex gum, mint flavor’s patent is valid until 2021-05-22 (FDA).

 

Trade Name

 

Habitrol, Nicoderm Cq, Nicotrol, Prostep
 

Common Name

 

nicotine
 

ChEMBL ID

 

CHEMBL3
 

Indication

 

tobacco use disorder, ulcerative colitis
 

Drug Class

 

Image (chem structure or protein)

Nicotine structure rendering